Browse the evidence

A ketogenic diet significantly improves quality of life (QoL) and reduces fatigue symptoms in individuals with overweight, particularly those with high baseline fatigue.

If you are overweight and struggle with fatigue, a ketogenic diet may help boost your energy and overall quality of life. This benefit seems most pronounced if you already feel fatigued. Stick to the diet for at least three months, ensure you are in ketosis, and monitor how your energy levels change.

Weight loss acts as a significant moderator for the effect of combined interventions on visceral fat area (VFA), but not for liver fat or intramuscular triglycerides (IMTG).

Losing weight helps reduce visceral fat, but it may not be enough to reduce liver or muscle fat. If you have concerns about liver or muscle fat, you may need additional strategies beyond just weight loss.

Time-restricted eating (TRE) combined with caloric restriction (CR) does not yield superior weight loss compared to caloric restriction alone in overweight and obese women.

If you are already restricting calories to lose weight, adding a strict eating window may not give you any extra weight loss benefit. You can achieve similar results with just calorie control.

A 1-month very-low-calorie ketogenic diet (VLCKD) in women with obesity causes a significant reduction in 24-hour energy expenditure (24hEE) and sleeping metabolic rate (SMR), primarily driven by the loss of lean soft tissue (LST) rather than metabolic adaptation alone.

If you follow a very-low-calorie ketogenic diet, expect your daily calorie burn to drop by about 10% after a month. This isn't just 'metabolic damage'; it's largely because you are lighter and have lost some muscle. To protect your metabolism, prioritize the protein target (1.2-1.5g/kg ideal body weight) and incorporate light resistance or walking to preserve lean tissue.

A 1-month VLCKD shifts substrate oxidation to favor fat and protein, resulting in a 62% fat mass loss and 38% lean soft tissue loss of total weight lost.

On a VLCKD, you will lose fat and muscle. In this study, 38% of the weight lost was lean tissue. To minimize this, ensure you are eating enough protein (1.2-1.5g/kg ideal body weight) and engaging in resistance exercise.

GLP-1 receptor agonists (e.g., semaglutide, liraglutide) achieve 10-15% weight loss and superior metabolic improvements compared to lifestyle changes alone, but are recommended for non-responders or those with comorbidities.

If lifestyle changes alone do not achieve sufficient weight loss or if you have obesity-related comorbidities, discuss GLP-1 receptor agonists (like semaglutide or liraglutide) with your doctor. These medications can lead to 10-15% weight loss and significant metabolic improvements, though they may cause gastrointestinal side effects. They are most effective when combined with lifestyle modifications.

Intermittent fasting (IF) produces weight loss and metabolic improvements comparable to continuous caloric restriction (CCR) in adults with overweight or obesity, without providing superior benefits.

If you are overweight or obese, intermittent fasting is a viable option for weight loss, but do not expect it to work better than simply eating fewer calories every day. Studies show that IF and continuous calorie restriction lead to similar weight loss (around 5% of body weight) and metabolic improvements over a year. Choose the method that you can stick with long-term, as adherence is key.

Lactobacillus sp. supplementation is safe and well-tolerated in non-comorbid obese individuals, with no significant adverse events reported.

You can take Lactobacillus probiotics with confidence regarding safety. Clinical trials show they are well-tolerated with no significant increase in side effects compared to a placebo.

Tirzepatide produces significant weight loss (mean 18.73%) and improves quality of life in overweight or obese adults without diabetes, but significantly increases the risk of adverse events compared to placebo.

Tirzepatide is a highly effective treatment for weight loss in non-diabetic overweight or obese adults, producing an average 18.73% body weight loss. However, it comes with a significantly higher risk of adverse events, particularly gastrointestinal issues, compared to placebo. Patients should be monitored closely for these side effects.

Increasing exercise volume from 3 sessions/week to 6 sessions/week further reduces fat mass and visceral adipose tissue, although the difference in fat-free mass preservation between 3 and 6 sessions was not statistically significant for absolute fat-free mass kg.

Even 3 days of exercise per week, combined with diet, significantly improves fat loss compared to diet alone. You do not need 6 days to see benefits, but 6 days provides greater fat loss and better muscle preservation.

Higher baseline body weight and BMI strongly predict greater absolute weight loss and fat mass reduction on a very low-calorie ketogenic diet (VLCKD), with men losing significantly more weight than women.

If you have a higher starting weight, you are likely to lose more absolute weight on a VLCKD than someone with a lower starting weight. Men also tend to lose more weight than women on this specific protocol. Use your baseline weight as a predictor of success rather than comparing yourself to others with different starting points.

Intermittent fasting downregulates enteroendocrine signaling, specifically GLP-1, GCG, and PYY, while upregulating PPAR-α, which correlates with improved lipid profiles.

The molecular changes observed (PPAR-α upregulation, GLP-1 downregulation) suggest that IF works by altering how your body processes fats and regulates hormones, not just by restricting calories. This may inform future targeted therapies.

The cardiovascular benefits of low-carbohydrate diets depend on the quality of macronutrients used to replace carbohydrates, not the degree of restriction itself.

If you reduce carbs, ensure you replace them with healthy foods like fiber-rich grains or unsaturated fats, not saturated fats. Simply cutting carbs without considering food quality does not improve heart health.

Flexible time-restricted eating leads to a spontaneous reduction in total energy intake without altering macronutrient composition.

If you use an 8-hour eating window, you will likely eat fewer calories without needing to count them or change your food choices. This spontaneous reduction in energy intake is a key driver of the fat loss seen with flexible TRE.

Increasing the regularity of meal times (reducing mealtime variability) leads to significant weight loss without the need for calorie restriction or changes in macronutrient composition.

Use a smartphone app to track your meals for two weeks. Identify the specific times you eat most frequently. Then, for the next six weeks, restrict your eating to only those specific times, aiming for a consistency of within 45 minutes of your usual times. Do not worry about changing what or how much you eat. This regularity helps your body's internal clock optimize metabolism, leading to weight loss.

Semaglutide improves glycemic control and metabolic parameters in patients with Type 2 Diabetes and obesity.

For those with Type 2 Diabetes, semaglutide helps manage blood sugar and aids in weight loss, though the weight loss effect may be more modest compared to non-diabetic patients.

Dietary fiber fermentation by gut microbiota produces short-chain fatty acids (SCFAs) which stimulate the secretion of gut peptides (GLP-1, PYY) via GPR41/GPR43 receptors, thereby improving glucose regulation and reducing energy intake.

To leverage your gut microbiome for better blood sugar control and appetite regulation, consume complex carbohydrates (dietary fibers) that resist digestion in the small intestine. These fibers reach the colon where bacteria ferment them into short-chain fatty acids (SCFAs). These SCFAs activate specific receptors (GPR41/43) on gut cells, triggering the release of hormones like GLP-1 and PYY that improve glucose handling and reduce hunger. Focus on sources like resistant starches and arabinoxylans.

Intestinal barrier disruption (leaky gut) allows translocation of bacterial endotoxins like LPS into circulation, driving systemic low-grade inflammation and contributing to metabolic and autoimmune diseases.

Maintaining gut barrier integrity through a diverse, fiber-rich diet supports the production of short-chain fatty acids (SCFAs) and healthy microbiota, which are critical for preventing the translocation of inflammatory bacterial components like LPS. This is a foundational aspect of metabolic and immune health, not just digestive comfort.

Dietary polyphenols reduce the risk of cardiovascular diseases (CVDs) by inhibiting LDL oxidation, preventing platelet aggregation, and improving endothelial function through nitric oxide signaling.

Include polyphenol-rich foods like tea, coffee, berries, and dark chocolate in your diet to support heart health. These foods help protect LDL from oxidation and improve blood vessel function, reducing cardiovascular risk.

Vitamin E supplementation (800 IU/day) significantly reverses steatohepatitis and reduces hepatic steatosis and ALT in non-diabetic patients, but long-term safety concerns exist.

Non-diabetic NAFLD patients may benefit from 800 IU/day Vitamin E to improve liver health, but should be aware of potential long-term risks.

Exogenous advanced glycation end products (AGEs) from heat-processed foods contribute significantly to systemic AGE accumulation, promoting oxidative stress, inflammation, and insulin resistance in type 2 diabetes.

Limit high-heat cooking methods like grilling, frying, and baking. Opt for moist-heat cooking (steaming, boiling, poaching) to reduce dietary AGE intake, which may help lower systemic inflammation and improve insulin sensitivity in type 2 diabetes.

SSB consumption increases the risk of type 2 diabetes (T2DM) and cardiovascular disease (CVD) independently of, and mediated by, weight gain.

Even if you are not overweight, limiting SSBs is important for preventing type 2 diabetes and heart disease. The sugars in these drinks can negatively affect your metabolism, insulin response, and blood lipids independently of your weight.

Adherence to a Western dietary pattern (high in processed foods, refined sugars, saturated/trans fats, and low in fiber/antioxidants) causes systemic inflammation, oxidative stress, and gut dysbiosis, leading to increased risk of chronic diseases including obesity, type 2 diabetes, cardiovascular disease, and cancer.

Reduce intake of ultra-processed foods, added sugars, and refined grains. Increase consumption of fruits, vegetables, whole grains, and nuts to improve antioxidant status and gut health. This shift addresses the root causes of inflammation and oxidative stress associated with chronic disease.

MBS serves as an effective bridge to other specialty surgeries (joint arthroplasty, hernia repair, organ transplantation) by reducing surgical risks and complications.

If you need joint surgery, hernia repair, or an organ transplant and are obese, getting MBS first can make the other surgery safer, shorter, and less likely to have complications.